Device Trial Radar · NCT04534660
Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
Last checked: Nov 20, 2026Latest source record: May 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Nov 10, 2020
Primary completion
Aug 24, 2021
Study completion Jun 23, 2023
Sponsor
- Lead sponsor
- Sofregen Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Symbio, LLC
- First posted
- Sep 1, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter (two clinical sites), unblinded, no control group, prospective feasibility study. Subject participation may last up to 24 months after enrollment. Treatment will be performed at Day 1 and optionally at Day 30, with the primary safety and effectiveness evaluation at 2 months. Subjects will continue extended follow-up evaluations at 4, 6, 12, 18 and 24 months after the final injection. The duration and follow-up schedule will be identical, independent of treatment performed.
Conditions
- Nasolabial Fold
- Cheek Augmentation
Interventions
SMI-01Device
SMI-01 is a device consisting of silk particles in a hydrogel carrier.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To obtain clinician feedback on overall ease of use of device on a scale of 0 -10 (0 being not easy and 10 being most easy)Time frame: Initial Treatment, Day 1
- Patient reported incidence of CTR's and any treatment emergent adverse eventsTime frame: Day 30
- Patient reported severity (mild, moderate or severe) of CTR's and any treatment emergent adverse eventsTime frame: Day 30
6 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
California Dermatology & Clinical Research Institute
Encinitas, California
Baumann Cosmetic & Research Institute
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.